POSTER SESSION II
Monday, March 26, 2007 — 1:00 PM - 4:30 PM
Convention Center, Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
67
Anterior Prostatic Anatomy: A Modern Surgical Pathology Perspective
(781)
VE Reuter, H Al-Ahmadie, A Gopalan, S Tickoo, SW Fine - Memorial Sloan Kettering Cancer Center, NY
Anterior Predominant Prostate Tumors: A Contemporary Look at Zone of Origin
(599)
HA Al-Ahmadie, SK Tickoo, A Gopalan, S Olgac, VE Reuter, SW Fine - Memorial Sloan Kettering Cancer Center, NY, NY
Prostatic Capsular Thickness Varies between Gland Regions and Is Impacted by Biologic Factors
(604)
M Amin, NS Goldstein - William Beaumont Hospital, Royal Oak, MI
The Prostatic Capsule Is an Integral Biologic Factor in the Presence or Absence of Extracapsular Extension by Adenocarcinoma
(673)
NS Goldstein - William Beaumont Hospital, Royal Oak, MI
Lymphocytic Vasculitis of the Prostate Transition Zone: Incidence in Surgical Specimens and Clinical Significance
(727)
A Lopez-Beltran, A Vidal, L Cheng, R Montironi - Cordoba University Medical School, Cordoba, Spain; Indiana University, Indianapolis, IN; Marche Region University, Ancona, Marche Region, Italy
Lymphovascular Invasion in Prostatic Adenocarcinoma
(655)
D Ertoy-Baydar, B Baseskioglu, H Ozen, PO Geyik - Hacettepe University Hospital, Ankara, Turkey
Lymphatic Vessel Density Does Not Associate with Tumor Grade in Prostate Cancer
(831)
Y Wang, E Genega, Y Fu - Beth Israel Deaconess Medical Center, Boston, MA
Lymphatic Vessel Density in Prostate Adenocarcinoma; Correlation with Clinicopathological Factors
(704)
KH Kim, S Lee, YW Kim, SG Chang, YK Park - Kyung Hee University, College of Medicine, Seoul, Korea; Kyung Hee University, Collge of Medicine, Seoul, Korea
Evolution of Granulomatous Prostatitis
(730)
X Lou, HX Li, JY Lei - Zhengzhou University School of Medicine, Zhengzhou, Henan, China; Cblpath, Rye Brook, NY
Characterization of Prostatic Adenocarcinoma Associated with Granulomatous Prostatitis
(726)
YQ Liu, H Lou, JY Lei - Zhengzhou University School of Medicine, Zhengzhou, Henan, China; Cblpath, Rye Brook, NY
Inflammatory Cells and Membrane Disruption in Prostate Carcinoma: Do They Have a Role in Tumor Invasion?
(752)
AM Nelson, A Tuteja, Y-G Man - Armed Forces Institute of Pathology, Washington, DC
Molecular Fixative-Induced Epithelial-Stromal Separation in Prostatic Carcinomas: A Potentially Helpful Feature
(783)
P Robinson, M Nadji, N Block, A Morales - University of Miami, Jackson Memorial Hospital, Miami, FL
The Relationship of Prostate Specific Antigen Recurrence and the Extent of Surgical Margin Positivity in Radical Prostatectomy Specimens
(738)
RA Marks, MO Koch, BE Juliar, L Cheng - Indiana University, Indianapolis, IN
The Relationship of Preoperative PSA Levels to Prostatic Weight and Tumor Size
(663)
B Furusato, I Rosner, D Osborn, J Cullen, Y Chen, C Davis, I Sesterhenn, D McLeod - Armed Forces Institute of Pathology, Washington, DC; Walter Reed Army Medical Cetner, Washington, DC; Center for Prostate Disease Research, Bethesda, MD
Renal Cell Tumor Typing According to WHO 2004 Scheme: Application to 935 Carcinomas Diagnosed from 1989 to 2003
(790)
MF Serrano, AS Kibel, T Bullock, PA Humphrey - Washington University School of Medicine, St. Louis, MO
Analysis of Observed Survival Outcomes in Histologically-Specified Renal Cell Carcinoma; 1993-1998 Cases from the National Cancer Data Base (NCDB)
(765)
GP Paner, J Ritchey, A Stewart, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; Chicago, IL
Differential Expression of Myocyte Enhancer Factor Isoforms in Rabdomyosarcoma
(1428)
GS Yu, T Gulick, L Balos - University at Buffalo, Buffalo, NY; Harvard Medical School, Boston, MA
Tumors Metastatic to the Kidney: A Clinicopathological Study of 30 Cases
(613)
G Barkan, C Magi-Galluzzi, L Sercia, E Wojcik, M Pickens, M Zhou - Cleveland Clinic, Cleveland, OH; Loyola University, Chicago, IL
Seminal Fluid as a Local Source of IGF-I in the Prostate: Implications for Prostate Cancer
(1407)
FU Garcia, K Reiss, C Sell, J Mullin - Drexel University College of Medicine, Philadelphia, PA; Temple University, Philadelphia, PA; Lankenau Institute for Medical Research, Wynnewood, PA
Lymph Nodes Metastases in Patients with Renal Cell Carcinoma: Correlation with Histopathologic Features
(795)
SS Shen, JY Ro, B Zhao, SJ Jung, LD Truong, AG Ayala - The Methodist Hospital, Houston, TX
Primary Clear Cell Renal Cell Carcinoma and Its Paired Metastasis: A Comparative Histomorphologic and Immunohistochemical Study
(819)
SK Tickoo, A Gopalan, HA Al-Ahmadie, SW Fine, S Olgac, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York
Diagnosing Metastatic Renal Cell Carcinoma. The Utility of PAX-2 Compared with the Renal Cell Carcinoma Marker Antigen
(845)
J Zhai, A Ozcan, A Kunda, C Hamilton, SS Shen, LD Truong - The Methodist Hospital, Houston, TX; Weill Medical of College of Cornell University, New York, NY; Baylor College of Medicine, Houston, TX; Gülhane Military Medical Academy & School of Medicine, Ankara, Turkey
PAX-2 in the Diagnosis of Primary Renal Tumors: Immunohistochemical Comparision with the Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin
(764)
A Ozcan, J Zhai, A Kunda, C Hamilton, SS Shen, LD Truong - The Methodist Hospital, Houston, TX; Baylor College of Medicine, Houston, TX; Weill Medical of College of Cornell University, New York, NY; Gülhane Military Medical Academy & School of Medicine, Etlik, Ankara, Turkey
Expression of Survivin, PHH3 and Serine/Threonine Kinase Mirk/Dyrk1B Distinguish Renal Oncocytoma from Chromophobe Renal Cell Carcinoma
(751)
MR Nasr, SS Shah, VS Chandan, JC Cheville, E Friedman, SK Landas - SUNY Upstate Medical University, Syracuse, NY; Mayo Clinic College of Medicine, Rochester, MN
Utility of S-100 and MSH-2 in Differentiating Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
(724)
F Lin, J Shi, XJ Yang, HL Wang, SS Shen, D Rukstails, C Schuerch - Geisinger Medical Center, Danville, PA; Northwestern Memorial Hospital, Chicago, IL; Washington University, St. Louis, MO; The Methodist Hospital, Houston, TX
Chromophobe Renal Cell Carcinoma: Feasibility of Using Tissue Microarrays for the Assessment of Diagnostic Cytogenetic Abnormalities by Fluorescence In Situ Hybridization
(624)
M Brunelli, S Gobbo, A Eccher, MM Mina, P Cossu-Rocca, F Menestrina, G Martignoni - Università di Verona, Verona, Italy; Università di Sassari, Sassari, Italy
Renal Oncocytoma and Chromophobe Renal Cell Carcinoma Share the Same LOH on the Short Arm of Chromosome 1; Comparison between FISH and LOH
(774)
MM Picken, B Chyna, RC Flanigan - Loyola University Medical Center, Maywood, IL
Hitherto-Unreported, Frequent Detection of the Same LOH on Chromosone 19q in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
(773)
MM Picken, B Chyna, RC Flanigan - Loyola University Medical Center, Maywood, IL
Concurrent Renal Oncocytoma and Malignant Renal Tumors: Analysis of 28 Cases
(755)
MM Nicolas, CG Wood, P Tamboli - M. D. Anderson Cancer Center, Houston, TX
Renal Oncocytoma: A Comparative Clinicopathologic Study and Fluorescent In-Situ Hybridization Analysis of 44 Cases with Long-Term Follow-Up
(650)
M Dvorakova, R Dhir, FA Monzon, SI Bastacky, KM Cieply, CR Sherer, TL Mercuri, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
The Use of Fluorescent In-Situ Hybridization and Immunohistochemistry To Differentiate Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
(651)
M Dvorakova, R Dhir, FA Monzon, SI Bastacky, KM Cieply, MB Acquafondata, KA Fuhrer, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
An Interphase FISH Panel Can Distinguish among Various Granular Renal Neoplasms
(749)
M Myrsiades, K Reichard, B Hall, J McKenney, M Che, D Grignon, J Hozier, L Cerilli - University of New Mexico, Albuquerque, NM; University of Arkansas, Little Rock, AR; Wayne State University, Detroit, MI
Oncocytoma Has High Endogenous Avidin-Binding Activity: Can EABA Be Used as a Marker in Differentiating Oncocytoma from Other Renal Cell Carcinoma Mimics?
(690)
J Hu, K Kanehira, T Pier, L Sebree, W Huang - University of Wisconsin, Madison, WI
Allelic Loss of Cyclin D1, an Oncogene, in Clear Cell Renal Cell Carcinoma and Renal Oncocytoma
(671)
N Gokden, L Li, S Schichman, BR Smoller, CY Fan - University of Arkansas for Medical Sciences, Little Rock, AR
CK7 and CD10 May Be Useful Markers in Differentiating Oncocytoma from Chromophobe Renal Cell Carcinoma
(700)
K Kanehira, T Pier, L Sebree, W Huang - University of Wisconsin, Madison, WI
button next to any title to add to Itinerary Planner...
Add
